Pathology & Oncology Research

, Volume 11, Issue 2, pp 92–97 | Cite as

Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma

  • Peter Simsa
  • Jean-Luc Teillaud
  • David I. Stott
  • József Tóth
  • Beatrix Kotlan


A major focus of tumor immunology is to reveal the potential role and capacity of immunocompetent cells found in different solid tumor tissues. The most abundant infiltrating cells (TIL), the T lymphocytes have been investigated in details concerning T-cell receptor usage and specificity. However, B cells have hardly been investigated in this respect, although high cellular B-cell infiltration has been correlated with improved patients’ survival in some breast carcinomas. This led to our objectives to study variable region gene usage of the tumor-infiltrating B cells in different breast carcinoma types. By defining the immunoglobulin repertoire of the tumor-infiltrating B lymphocytes in the most common invasive ductal carcinoma (IDC) of the breast we compared it to the rare medullary breast carcinoma (MBC). After phenotyping infiltrating ductal carcinomas, B cells were obtained from tumor tissue by microdissection technique. Numerous rearranged TIL-B immunoglobulin heavy chain V genes (VH) were amplified, cloned, sequenced, and comparatively analyzed. Some characteristics were found for both breast carcinoma types. The immunoglobulins produced by TIL-B in ductal carcinoma are highly matured and oligoclonal. We conclude that Ig variable region gene usage reveals similar and distinguishable characteristics of TIL-B immunoglobulin repertoires, which are representative of the nature of the immune responses in invasive ductal and medullary breast carcinomas.

Key words

immunoglobulin variable region breast ductal carcinoma tumor-infiltrating lymphocytes 



amino acid


complementary determining region


ductal carcinoma in situ


follicular dendritic cell


framework region


invasive ductal carcinoma




medullary breast carcinoma


peripheral blood mononuclear cell


tumor-infiltrating T lymphocytes


tumor-infiltrating B lymphocytes


Ig heavy chain variable region


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hadden JW: The immunology and immunotherapy of breast cancer: an update. Int J Immunopharmacol 21: 79–101, 1999PubMedCrossRefGoogle Scholar
  2. 2.
    Ben-Hur H, Cohen O, Schneider D, et al: The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study. Anticancer Res 22: 1231–1238, 2002PubMedGoogle Scholar
  3. 3.
    Di Girolamo V, Lauens RP, Coronato S, et al: Quantitative and functional study of breast cancer axillary lymph nodes and those draining other malignant tumors. J Exp Clin Cancer Res 19:155–159, 2000PubMedGoogle Scholar
  4. 4.
    Allan CP, Turtle CJ, Mainwaring PN, et al: The immune response to breast cancer, and the case for DC immunotherapy. Cytotherapy 6:154–163, 2004PubMedCrossRefGoogle Scholar
  5. 5.
    Balch CM, Riley LB, Bae YJ, et al: Patterns of human tumorinfiltrating lymphocytes in 120 human cancers. Arch Surg 125:200–205, 1990PubMedGoogle Scholar
  6. 6.
    Schwartzentruber DJ, Solomon D, Rosenberg SA, et al: Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion. J Immunother 12:1–12, 1992PubMedCrossRefGoogle Scholar
  7. 7.
    Lin E, Pollard JW: Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90:2053–8, 2004PubMedCrossRefGoogle Scholar
  8. 8.
    Ladányi A: Function and prognostic significance of immune cells infiltrating human tumors. (In Hungarian) Magy Onkol 48:49–56, 2004PubMedGoogle Scholar
  9. 9.
    Filaci G, Fravegy M, Fenoglio D, et al: Non-antigen specific CD8+ T suppressor lymphocytes. Clin Exp Med 4:86–92, 2004PubMedCrossRefGoogle Scholar
  10. 10.
    Whitford P, Mallon EA, George WD, et al: Flow cytometric analysis of tumor infiltrating lymphocytes in breast cancer. Br J Cancer 62:971–975, 1990PubMedGoogle Scholar
  11. 11.
    Lee RS, Schlumberger M, Caillou B, et al: Phenotypic and functional characterisation of tumor-infiltrating lymphocytes. Eur J Cancer 32: 1233–1239, 1996CrossRefGoogle Scholar
  12. 12.
    Chin Y, Janssens J, Bleus J, et al: Characterization of tumor infiltrating lymphocytes in human breast cancer. Eur J Cancer Prev 2 (Suppl. 33): 27–31, 1993PubMedGoogle Scholar
  13. 13.
    Grekou AN, Toliou T, Stravoravdi P, et al: Correlation of apoptosis with the distribution and composition of lymphocytic infiltrate in human breast carcinomas. Anticancer Res 16:3991–3995, 1996PubMedGoogle Scholar
  14. 14.
    Ridolfi RL, Rosen PP, Port A, et al: Medullary carcinoma of the breast. A clinicopathology study with 10 year follow-up. Cancer 40:1365–1385, 1977PubMedCrossRefGoogle Scholar
  15. 15.
    Coronella JA, Spier C, Welch M, et al: Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast. J Immunol 169:1829–1836, 2002PubMedGoogle Scholar
  16. 16.
    Nzula S, Going JJ, Stott DI: Antigen driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas. Cancer Res 63: 3275–3280, 2003PubMedGoogle Scholar
  17. 17.
    Moore OS, Foote FW: The relatively favourable prognosis of medullary carcinoma of the breast. Cancer 2: 635–640, 1949PubMedCrossRefGoogle Scholar
  18. 18.
    Marks JD, Tristem M, Karpas A, et al: Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes. Eur J Immunol 21:985–991, 1991PubMedCrossRefGoogle Scholar
  19. 19.
    Sims GP, Shiono H, Willcox N, et al: Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J Immunol 167:1935–1944, 2001PubMedGoogle Scholar
  20. 20.
    Tomlinson IM, Williams SC, Ignatovich O, et al: Human VBASE directory of immunoglobulin genes. Cambridge, UK: MRC Centre for Protein Engineering, 1997Google Scholar
  21. 21.
    Kotlan B, Gruel N, Zafrani B, et al: Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma. Immunol Lett 65:143–151, 1999PubMedCrossRefGoogle Scholar
  22. 22.
    Cuisinier AM, Guigou V, Boubli,et al: Preferential expression of VH5 and VH6 immunoglobulin genes in early human B-cell ontogeny. Scand J Immunol 30: 493–497, 1989PubMedCrossRefGoogle Scholar
  23. 23.
    Kotlan B, Simsa P, Foldi J, et al: Immunoglobulin repertoire of B lymphocytes infiltrating breast medullary carcinoma. Human Antibodies 12: 113–121, 2003PubMedGoogle Scholar
  24. 24.
    Ito T, Saga S, Nagayoshi S, et al: Class distribution of immunoglobulin-containing plasma cells in the stroma of medullary carcinoma of breast. Breast Cancer Res Treat 7:97–103, 1986PubMedCrossRefGoogle Scholar
  25. 25.
    Lazzaro B, Anderson AE, Kajdacsy-Balla A, et al: Antigenic characterization of medullary carcinoma of the breast: HLADR expression in lymph node positive cases. Appl Immunohistochem Mol Morphol 9: 234–241, 2001PubMedCrossRefGoogle Scholar
  26. 26.
    Gaffey MJ, Frierson HF, Mills SE, et al: Medullary carcinoma of the breast: identification of lymphocyte subpopulations and their significance. Mod Pathol 6:721–728, 1993PubMedGoogle Scholar
  27. 27.
    Berek C, Berger A, Apel M: Maturation of the immune response in germinal centers. Cell 67:1121–1129, 1991PubMedCrossRefGoogle Scholar
  28. 28.
    O’Brien PM, Tsirimonaki E, Coomber DW, et al: Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection. Cancer Immunol Immunother 50:523–532, 2001PubMedCrossRefGoogle Scholar
  29. 29.
    Friedman DF, Kraj P, Silberstein LE: VH4.21 Expression in the normal human B-cell repertoire. In: Immunoglobulin Gene Expression in Development and Disease. (Eds: Casali P, Silberstein LE) Ann New York Acad Sc 764:264–274, 1995Google Scholar
  30. 30.
    Stollar BD: The expressed heavy chain V gene repertoire of circulating B cells in normal adults. In: Immunoglobulin Gene Expression in Development and Disease. (Eds: Casali P, Silberstein LE) Ann New York Acad Sc 764:264–274, 1995Google Scholar
  31. 31.
    Kotlan B, Simsa P, Teillaud JL et al: Novel ganglioside antigen identified by B cells in human medullary breast carcinomas. The proof of principle concerning the infiltrating B lymphocytes. J Immun, 2005 (in press)Google Scholar

Copyright information

© Arányi Lajos Foundation 2005

Authors and Affiliations

  • Peter Simsa
    • 1
  • Jean-Luc Teillaud
    • 2
  • David I. Stott
    • 3
  • József Tóth
    • 4
  • Beatrix Kotlan
    • 1
  1. 1.National Medical CenterInstitute of Haematology and ImmunologyBudapestHungary
  2. 2.INSERM U255Centre de Recherches Biomedicales des CordeliersParisFrance
  3. 3.Division of Immunology, Infection and InflammationUniversity of Glasgow, Western InfirmaryGlasgowUK
  4. 4.National Institute of OncologyBudapestHungary

Personalised recommendations